Pharmacology and anti‐addiction effects of the novel κ opioid receptor agonist<scp>M</scp>esyl<scp>S</scp>al<scp>B</scp>, a potent and long‐acting analogue of salvinorin<scp>A</scp>
Bridget Simonson(Broad Institute), Bronwyn M. Kivell(Victoria University of Wellington), Nitin Kumar(University of Michigan), Leigh C. Walker(Florey Institute of Neuroscience and Mental Health), Amy Ewald(Victoria University of Wellington), Aashish S. Morani(Victoria University of Wellington), John H. Miller(Santa Fe Institute), Denise S. Simpson(University of Kansas), Thomas E. Prisinzano(University of Kentucky)
Cited by 64
Related Papers
Small RNA Sequencing across Diverse Biofluids Identifies Optimal Methods for exRNA Isolation
|Cell|2019|312
Fern gametophytes as experimental material
|The Botanical Review|1968|232
Development of Functionally Selective, Small Molecule Agonists at Kappa Opioid Receptors
|Journal of Biological Chemistry|2013|148
Synthesis and κ-Opioid Receptor Activity of Furan-Substituted Salvinorin A Analogues
|Journal of Medicinal Chemistry|2014|115
Anterior Insular Cortex is Critical for the Propensity to Relapse Following Punishment-Imposed Abstinence of Alcohol Seeking
|Journal of Neuroscience|2018|77